Production (Stage)
Amedisys, Inc.
AMED
$93.43
-$0.13-0.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 323.69% | -205.48% | -34.86% | 140.24% | -42.96% |
| Total Depreciation and Amortization | 4.95% | 8.06% | 6.45% | 2.36% | 2.71% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | -401.54% | 256.11% | -57.52% | -89.82% | 4.74% |
| Change in Net Operating Assets | -10.00% | 102.95% | 202.72% | -153.14% | -96.39% |
| Cash from Operations | 43.63% | 16.52% | 1,173.09% | -13.91% | -125.20% |
| Capital Expenditure | 54.49% | 41.33% | -40.75% | 0.65% | -97.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 56.28% | 7.10% | -1,556.25% | 97.12% | -108.38% |
| Cash from Investing | 55.22% | 37.22% | -133.30% | 79.72% | -106.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.98% | -8.17% | -52.75% | 54.35% | 85.88% |
| Issuance of Common Stock | -- | -- | -89.92% | -- | -- |
| Repurchase of Common Stock | -364.18% | 38.00% | 30.27% | -64.13% | 52.83% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -177.88% | 79.78% | -6,219.51% | 74.16% | 192.90% |
| Cash from Financing | -55.56% | 16.54% | -141.24% | -28.55% | 84.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.11% | 28.86% | 613.81% | -12.86% | -221.33% |